Disease Surveillance: Ebola cases in the Democratic Republic of the Congo have reached 8,787, with 4,242 confirmed deaths, according to WHO figures reported for Oct. 7. Cancer Imaging: A 200-patient study found FAPI PET/CT detected ovarian cancer spread in the abdomen more accurately than conventional CT, potentially helping guide surgery decisions. Drug Development: Merck reported one-year results from its pivotal trial of investigational remigromig for diabetic macular edema; both doses met the trial’s non-inferiority benchmark against ranibizumab, but neither proved superior. Drug Pricing: PhRMA is suing to block a Medicare rule tying some hospital drug prices to costs in other countries, calling it an overreach. Brain Health: A long-term study linked nitrate exposure from tap water and animal products with higher dementia rates, while vegetable-derived nitrates were associated with lower rates; the findings do not prove cause and effect. Drug Safety: A UK watchdog censured CSL Seqirus over more than £730,000 in grants that were undisclosed or did not identify the ultimate recipient.